Ally Bridge Group »

Avalo Therapeutics Ord shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 178k 12.71

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Silverarc Capital Management
Vanguard Group
RA Capital Management
Citadel Advisors
TCG Crossover Management
Commodore Capital
Velan Capital Investment Management
Adage Capital Partners GP

View all funds holding Avalo Therapeutics Ord